dievini Hopp BioTech holding
Overview
dievini Hopp BioTech holding is a family office and investment firm for SAP co-founder Dietmar Hopp that focuses on innovative life and health sciences companies in Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Molecular Health | Nov 2015 | VC Round | Lead |
| AaviGen | Jul 2023 | Series B | Lead |
| Apogenix | Dec 2021 | Grant | Lead |
| Novaliq | Oct 2018 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is dievini Hopp BioTech holding based?
dievini Hopp BioTech holding is headquartered in Walldorf, Germany.
When was dievini Hopp BioTech holding founded?
dievini Hopp BioTech holding was founded in 2005.
How many portfolio companies does dievini Hopp BioTech holding have?
dievini Hopp BioTech holding has 4 portfolio companies in Caplight's dataset.
What are some companies in dievini Hopp BioTech holding's portfolio?
Portfolio companies visible on Caplight include Molecular Health, AaviGen, Apogenix, Novaliq.
What was dievini Hopp BioTech holding's most recent investment shown here?
dievini Hopp BioTech holding's most recent investment in this portfolio sample was in AaviGen in 2023.
What sectors does dievini Hopp BioTech holding focus on?
dievini Hopp BioTech holding focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does dievini Hopp BioTech holding focus on?
dievini Hopp BioTech holding typically invests at the MultiStage stage.
What is dievini Hopp BioTech holding's AUM?
dievini Hopp BioTech holding's assets under management are estimated between $250.0M and $500.0M.